Please login to the form below

Not currently logged in
Email:
Password:

EU

This page shows the latest EU news and features for those working in and with pharma, biotech and healthcare.

Takeda announces CHMP recommendation for Adcetris in Hodgkin lymphoma

Takeda announces CHMP recommendation for Adcetris in Hodgkin lymphoma

The Committee for Medicinal Products for Human Use (CHMP) has specifically recommended that the antibody-drug conjugate (ADC), which is already approved in the EU for certain lymphoma patients, be used ... The CHMP’s recommendation will now be reviewed

Latest news

More from news
Approximately 148 fully matching, plus 2,464 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 9 fully matching, plus 224 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 68 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 143 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Man vs microbe: the fight against antimicrobial resistance
How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
HOW TO TRANSFORM YOUR HEALTHCARE BRAND MARKETING FROM MULTI-CHANNEL TO OMNICHANNEL
In a previous blog, we outlined the role of omnichannel in healthcare and the importance of personalised communications with the suggestion of using modular content to support an omnichannel approach....